| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | Fc-gamma receptor I complex binding | 5.84e-07 | 7 | 230 | 4 | GO:0034988 | |
| GeneOntologyMolecularFunction | peptidyltransferase activity | 2.94e-05 | 6 | 230 | 3 | GO:0000048 | |
| GeneOntologyMolecularFunction | leukotriene-C(4) hydrolase | 2.94e-05 | 6 | 230 | 3 | GO:0002951 | |
| GeneOntologyMolecularFunction | leukotriene C4 gamma-glutamyl transferase activity | 8.09e-05 | 8 | 230 | 3 | GO:0103068 | |
| GeneOntologyMolecularFunction | immunoglobulin receptor binding | 8.80e-05 | 21 | 230 | 4 | GO:0034987 | |
| GeneOntologyMolecularFunction | glutathione hydrolase activity | 1.20e-04 | 9 | 230 | 3 | GO:0036374 | |
| GeneOntologyMolecularFunction | hydroxymethylglutaryl-CoA synthase activity | 1.32e-04 | 2 | 230 | 2 | GO:0004421 | |
| GeneOntologyMolecularFunction | nitrite reductase activity | 2.32e-04 | 11 | 230 | 3 | GO:0098809 | |
| GeneOntologyMolecularFunction | secondary active sulfate transmembrane transporter activity | 2.32e-04 | 11 | 230 | 3 | GO:0008271 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 4.63e-04 | 196 | 230 | 9 | GO:0005319 | |
| GeneOntologyMolecularFunction | sulfate transmembrane transporter activity | 7.56e-04 | 16 | 230 | 3 | GO:0015116 | |
| GeneOntologyMolecularFunction | omega peptidase activity | 7.56e-04 | 16 | 230 | 3 | GO:0008242 | |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 7.56e-04 | 36 | 230 | 4 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 7.56e-04 | 36 | 230 | 4 | GO:0015662 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol binding | 9.10e-04 | 17 | 230 | 3 | GO:0005545 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on other nitrogenous compounds as donors | 9.10e-04 | 17 | 230 | 3 | GO:0016661 | |
| GeneOntologyBiologicalProcess | positive regulation of type I hypersensitivity | 1.05e-06 | 8 | 232 | 4 | GO:0001812 | |
| GeneOntologyBiologicalProcess | regulation of type I hypersensitivity | 1.88e-06 | 9 | 232 | 4 | GO:0001810 | |
| GeneOntologyBiologicalProcess | positive regulation of type IIa hypersensitivity | 3.11e-06 | 10 | 232 | 4 | GO:0001798 | |
| GeneOntologyBiologicalProcess | type I hypersensitivity | 3.11e-06 | 10 | 232 | 4 | GO:0016068 | |
| GeneOntologyBiologicalProcess | positive regulation of type II hypersensitivity | 3.11e-06 | 10 | 232 | 4 | GO:0002894 | |
| GeneOntologyBiologicalProcess | regulation of type IIa hypersensitivity | 4.84e-06 | 11 | 232 | 4 | GO:0001796 | |
| GeneOntologyBiologicalProcess | regulation of type II hypersensitivity | 4.84e-06 | 11 | 232 | 4 | GO:0002892 | |
| GeneOntologyBiologicalProcess | antibody-dependent cellular cytotoxicity | 1.03e-05 | 13 | 232 | 4 | GO:0001788 | |
| GeneOntologyBiologicalProcess | phagocytosis, engulfment | 1.24e-05 | 69 | 232 | 7 | GO:0006911 | |
| GeneOntologyBiologicalProcess | complement activation | 1.37e-05 | 70 | 232 | 7 | GO:0006956 | |
| GeneOntologyBiologicalProcess | type IIa hypersensitivity | 1.93e-05 | 15 | 232 | 4 | GO:0001794 | |
| GeneOntologyBiologicalProcess | positive regulation of hypersensitivity | 1.93e-05 | 15 | 232 | 4 | GO:0002885 | |
| GeneOntologyBiologicalProcess | type II hypersensitivity | 1.93e-05 | 15 | 232 | 4 | GO:0002445 | |
| GeneOntologyBiologicalProcess | plasma membrane invagination | 2.79e-05 | 78 | 232 | 7 | GO:0099024 | |
| GeneOntologyBiologicalProcess | positive regulation of acute inflammatory response to antigenic stimulus | 3.31e-05 | 17 | 232 | 4 | GO:0002866 | |
| GeneOntologyBiologicalProcess | regulation of hypersensitivity | 5.29e-05 | 19 | 232 | 4 | GO:0002883 | |
| GeneOntologyBiologicalProcess | membrane invagination | 5.66e-05 | 87 | 232 | 7 | GO:0010324 | |
| GeneOntologyBiologicalProcess | cysteine biosynthetic process | 7.55e-05 | 8 | 232 | 3 | GO:0019344 | |
| GeneOntologyBiologicalProcess | regulation of response to external stimulus | SIGLEC9 ESR1 SARM1 CLASP2 GGTLC2 GRAMD4 GGT1 KIAA0319 IFIH1 NEO1 PTPRJ ADAM17 VEGFD IL23R UNC13B VWF DDX60 MUC16 NLRP3 THBS1 THBS4 NMI IGHG1 IGHG2 IGHG3 IGHG4 GGTLC1 REG3A DUSP10 MST1L PCBP2 | 7.72e-05 | 1316 | 232 | 31 | GO:0032101 |
| GeneOntologyBiologicalProcess | positive regulation of inflammatory response to antigenic stimulus | 1.17e-04 | 23 | 232 | 4 | GO:0002863 | |
| GeneOntologyBiologicalProcess | cell-cell junction maintenance | 1.17e-04 | 23 | 232 | 4 | GO:0045217 | |
| GeneOntologyBiologicalProcess | isoprenoid biosynthetic process via mevalonate | 1.26e-04 | 2 | 232 | 2 | GO:1902767 | |
| GeneOntologyBiologicalProcess | farnesyl diphosphate biosynthetic process, mevalonate pathway | 1.26e-04 | 2 | 232 | 2 | GO:0010142 | |
| GeneOntologyBiologicalProcess | complement activation, classical pathway | 1.31e-04 | 44 | 232 | 5 | GO:0006958 | |
| GeneOntologyBiologicalProcess | cortical actin cytoskeleton organization | 1.46e-04 | 45 | 232 | 5 | GO:0030866 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity | 1.59e-04 | 10 | 232 | 3 | GO:1990264 | |
| GeneOntologyBiologicalProcess | leukotriene D4 biosynthetic process | 1.59e-04 | 10 | 232 | 3 | GO:1901750 | |
| GeneOntologyBiologicalProcess | peptide modification | 1.59e-04 | 10 | 232 | 3 | GO:0031179 | |
| GeneOntologyBiologicalProcess | hypersensitivity | 1.64e-04 | 25 | 232 | 4 | GO:0002524 | |
| GeneOntologyBiologicalProcess | glutathione catabolic process | 2.17e-04 | 11 | 232 | 3 | GO:0006751 | |
| GeneOntologyBiologicalProcess | regulation of acute inflammatory response to antigenic stimulus | 2.23e-04 | 27 | 232 | 4 | GO:0002864 | |
| GeneOntologyBiologicalProcess | myelin assembly | 2.58e-04 | 28 | 232 | 4 | GO:0032288 | |
| GeneOntologyBiologicalProcess | leukotriene D4 metabolic process | 2.87e-04 | 12 | 232 | 3 | GO:1901748 | |
| GeneOntologyBiologicalProcess | positive regulation of myeloid leukocyte mediated immunity | 3.40e-04 | 30 | 232 | 4 | GO:0002888 | |
| GeneOntologyBiologicalProcess | vesicle-mediated transport between endosomal compartments | 4.13e-04 | 56 | 232 | 5 | GO:0098927 | |
| GeneOntologyBiologicalProcess | cortical cytoskeleton organization | 4.48e-04 | 57 | 232 | 5 | GO:0030865 | |
| GeneOntologyBiologicalProcess | B cell differentiation | 4.70e-04 | 201 | 232 | 9 | GO:0030183 | |
| GeneOntologyCellularComponent | cell projection membrane | MYO1C NCKAP1 CLASP2 EPB41L3 UNC5A PTPRJ NPC1L1 ADAM17 SLC26A2 SLC7A9 PLEK2 MTMR6 MTTP KIRREL1 SLC5A8 ATP2B1 ENPEP | 6.65e-06 | 431 | 231 | 17 | GO:0031253 |
| GeneOntologyCellularComponent | apical part of cell | ATP7B SLC5A7 SLC22A7 HAVCR1 INSC NPC1L1 PTPRQ AFDN ADAM17 PLEC ANK2 SLC26A2 SLC7A9 CD34 REG3A SLC5A8 PARD3 ATP2B1 ENPEP ATP4A | 1.02e-05 | 592 | 231 | 20 | GO:0045177 |
| GeneOntologyCellularComponent | IgG immunoglobulin complex | 1.33e-05 | 14 | 231 | 4 | GO:0071735 | |
| GeneOntologyCellularComponent | immunoglobulin complex, circulating | 3.09e-05 | 17 | 231 | 4 | GO:0042571 | |
| GeneOntologyCellularComponent | apical plasma membrane | SLC5A7 SLC22A7 HAVCR1 NPC1L1 PTPRQ ADAM17 PLEC ANK2 SLC26A2 SLC7A9 CD34 SLC5A8 PARD3 ATP2B1 ENPEP ATP4A | 1.11e-04 | 487 | 231 | 16 | GO:0016324 |
| GeneOntologyCellularComponent | leading edge membrane | MYO1C NCKAP1 CLASP2 EPB41L3 UNC5A PTPRJ ADAM17 PLEK2 MTMR6 ATP2B1 | 1.21e-04 | 210 | 231 | 10 | GO:0031256 |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | MYO1C HAVCR1 NPC1L1 PTPRQ PLEC PKHD1L1 SLC7A9 MTTP SLC5A8 ENPEP | 1.97e-04 | 223 | 231 | 10 | GO:0098862 |
| GeneOntologyCellularComponent | brush border | 2.95e-04 | 152 | 231 | 8 | GO:0005903 | |
| GeneOntologyCellularComponent | cell leading edge | KLHL2 GBF1 MYO1C NCKAP1 CLASP2 EPB41L3 UNC5A PTPRJ ADAM17 PLEKHH2 ARHGEF6 PLEK2 MTMR6 ATP2B1 PLCE1 | 4.75e-04 | 500 | 231 | 15 | GO:0031252 |
| MousePheno | absent memory B cells | 3.10e-08 | 4 | 187 | 4 | MP:0008094 | |
| MousePheno | decreased memory B cell number | 3.71e-06 | 9 | 187 | 4 | MP:0008729 | |
| MousePheno | increased anti-double stranded DNA antibody level | 4.10e-06 | 70 | 187 | 8 | MP:0004762 | |
| MousePheno | decreased IgG2c level | 9.51e-06 | 11 | 187 | 4 | MP:0008897 | |
| MousePheno | abnormal memory B cell number | 9.51e-06 | 11 | 187 | 4 | MP:0008093 | |
| MousePheno | increased plasma cell number | 1.39e-05 | 40 | 187 | 6 | MP:0008097 | |
| MousePheno | abnormal long bone epiphyseal plate morphology | ESR1 GGTLC2 GGT1 ADAM17 PRRX1 POC1A SLC26A2 NLRP3 CEMIP SLC35A3 GGTLC1 | 1.99e-05 | 172 | 187 | 11 | MP:0003055 |
| MousePheno | increased susceptibility to type I hypersensitivity reaction | 2.14e-05 | 43 | 187 | 6 | MP:0005596 | |
| MousePheno | abnormal circulating glutathione level | 2.31e-05 | 5 | 187 | 3 | MP:0030652 | |
| MousePheno | increased circulating glutathione level | 2.31e-05 | 5 | 187 | 3 | MP:0030653 | |
| MousePheno | glutathionuria | 2.31e-05 | 5 | 187 | 3 | MP:0013730 | |
| MousePheno | increased glutathione level | 2.31e-05 | 5 | 187 | 3 | MP:0012606 | |
| MousePheno | increased anti-nuclear antigen antibody level | 2.35e-05 | 115 | 187 | 9 | MP:0004794 | |
| MousePheno | decreased long bone epiphyseal plate size | 2.45e-05 | 44 | 187 | 6 | MP:0006396 | |
| MousePheno | abnormal memory B cell morphology | 2.80e-05 | 14 | 187 | 4 | MP:0002440 | |
| MousePheno | abnormal plasma cell differentiation | 3.77e-05 | 15 | 187 | 4 | MP:0008099 | |
| MousePheno | abnormal epiphyseal plate morphology | ESR1 GGTLC2 GGT1 ADAM17 PRRX1 POC1A SLC26A2 NLRP3 CEMIP SLC35A3 GGTLC1 | 3.91e-05 | 185 | 187 | 11 | MP:0006395 |
| MousePheno | abnormal copulatory plug deposition | 4.98e-05 | 16 | 187 | 4 | MP:0030982 | |
| MousePheno | enhanced humoral immune response | 6.44e-05 | 17 | 187 | 4 | MP:0020155 | |
| MousePheno | increased autoantibody level | 7.41e-05 | 133 | 187 | 9 | MP:0003725 | |
| MousePheno | decreased circulating cysteine level | 7.93e-05 | 7 | 187 | 3 | MP:0030626 | |
| MousePheno | failure of superovulation | 8.19e-05 | 18 | 187 | 4 | MP:0031422 | |
| MousePheno | abnormal cartilage development | ENPP1 GGTLC2 GGT1 ADAM17 PRRX1 POC1A SLC26A2 NLRP3 SLC35A3 GGTLC1 | 1.06e-04 | 172 | 187 | 10 | MP:0000164 |
| MousePheno | decreased cysteine level | 1.26e-04 | 8 | 187 | 3 | MP:0030623 | |
| MousePheno | epididymis hypoplasia | 1.26e-04 | 8 | 187 | 3 | MP:0004932 | |
| MousePheno | abnormal plasma cell number | 1.32e-04 | 59 | 187 | 6 | MP:0008096 | |
| MousePheno | abnormal IgG2c level | 1.55e-04 | 21 | 187 | 4 | MP:0020178 | |
| MousePheno | increased circulating xanthine level | 1.78e-04 | 2 | 187 | 2 | MP:0031490 | |
| MousePheno | abnormal circulating xanthine level | 1.78e-04 | 2 | 187 | 2 | MP:0031488 | |
| MousePheno | nervous | 1.86e-04 | 9 | 187 | 3 | MP:0008912 | |
| MousePheno | uterus hypoplasia | 2.25e-04 | 23 | 187 | 4 | MP:0001121 | |
| MousePheno | failure of copulatory plug deposition | 2.64e-04 | 10 | 187 | 3 | MP:0030983 | |
| MousePheno | seminal vesicle hypoplasia | 2.64e-04 | 10 | 187 | 3 | MP:0005148 | |
| MousePheno | ovary hypoplasia | 2.64e-04 | 10 | 187 | 3 | MP:0005158 | |
| MousePheno | crystalluria | 2.64e-04 | 10 | 187 | 3 | MP:0009645 | |
| MousePheno | tubulointerstitial nephritis | 2.67e-04 | 24 | 187 | 4 | MP:0011405 | |
| MousePheno | abnormal copulation behavior | 2.67e-04 | 24 | 187 | 4 | MP:0009697 | |
| MousePheno | abnormal circulating cysteine level | 3.59e-04 | 11 | 187 | 3 | MP:0030624 | |
| MousePheno | absent tertiary ovarian follicles | 3.59e-04 | 11 | 187 | 3 | MP:0011130 | |
| MousePheno | decreased bone mass | 3.85e-04 | 100 | 187 | 7 | MP:0004016 | |
| MousePheno | abnormal plasma cell morphology | 4.95e-04 | 75 | 187 | 6 | MP:0002439 | |
| MousePheno | increased circulating hypoxanthine level | 5.29e-04 | 3 | 187 | 2 | MP:0031487 | |
| MousePheno | abnormal circulating hypoxanthine level | 5.29e-04 | 3 | 187 | 2 | MP:0031485 | |
| MousePheno | increased urine hypoxanthine level | 5.29e-04 | 3 | 187 | 2 | MP:0031484 | |
| MousePheno | abnormal urine hypoxanthine level | 5.29e-04 | 3 | 187 | 2 | MP:0031482 | |
| MousePheno | aminoaciduria | 5.67e-04 | 29 | 187 | 4 | MP:0003311 | |
| MousePheno | abnormal cartilage morphology | ENPP1 ESR1 GGTLC2 GGT1 PGAP1 ADAM17 PRRX1 POC1A SLC26A2 NLRP3 CEMIP SLC35A3 GGTLC1 | 5.96e-04 | 336 | 187 | 13 | MP:0000163 |
| MousePheno | abnormal cysteine level | 6.10e-04 | 13 | 187 | 3 | MP:0030621 | |
| MousePheno | decreased glutathione level | 6.10e-04 | 13 | 187 | 3 | MP:0012604 | |
| MousePheno | abnormal glutathione level | 6.10e-04 | 13 | 187 | 3 | MP:0012603 | |
| MousePheno | increased germinal center B cell number | 7.36e-04 | 31 | 187 | 4 | MP:0008177 | |
| MousePheno | priapism | 7.69e-04 | 14 | 187 | 3 | MP:0003415 | |
| MousePheno | abnormal fertilization | ESR1 LCN8 SLC26A8 SLC22A14 PGAP1 GOLGA3 OR4M1 APOB OR4M2 NDC1 | 7.88e-04 | 221 | 187 | 10 | MP:0005410 |
| MousePheno | abnormal long bone hypertrophic chondrocyte zone | 8.03e-04 | 113 | 187 | 7 | MP:0000165 | |
| MousePheno | abnormal type I hypersensitivity reaction | 9.06e-04 | 84 | 187 | 6 | MP:0002531 | |
| Domain | WD40_repeat_dom | DCAF6 IFT172 WDR49 ANAPC4 WDR48 POC1A UBR4 NBEA PALB2 TLE3 GNB5 CSTF1 WDFY3 CFAP57 | 1.82e-05 | 297 | 228 | 14 | IPR017986 |
| Domain | WD_REPEATS_1 | DCAF6 IFT172 HERC2 WDR49 WDR48 POC1A NBEA PALB2 TLE3 GNB5 CSTF1 WDFY3 CFAP57 | 3.94e-05 | 278 | 228 | 13 | PS00678 |
| Domain | WD_REPEATS_2 | DCAF6 IFT172 HERC2 WDR49 WDR48 POC1A NBEA PALB2 TLE3 GNB5 CSTF1 WDFY3 CFAP57 | 4.09e-05 | 279 | 228 | 13 | PS50082 |
| Domain | WD_REPEATS_REGION | DCAF6 IFT172 HERC2 WDR49 WDR48 POC1A NBEA PALB2 TLE3 GNB5 CSTF1 WDFY3 CFAP57 | 4.09e-05 | 279 | 228 | 13 | PS50294 |
| Domain | GGT_peptidase | 6.06e-05 | 7 | 228 | 3 | IPR000101 | |
| Domain | G_glu_transpept | 6.06e-05 | 7 | 228 | 3 | PF01019 | |
| Domain | G_GLU_TRANSPEPTIDASE | 6.06e-05 | 7 | 228 | 3 | PS00462 | |
| Domain | - | DCAF6 IFT172 WDR49 ANAPC4 WDR48 POC1A NBEA PALB2 SEMA3D TLE3 GNB5 CSTF1 WDFY3 CFAP57 | 6.34e-05 | 333 | 228 | 14 | 2.130.10.10 |
| Domain | WD40/YVTN_repeat-like_dom | DCAF6 IFT172 WDR49 ANAPC4 WDR48 POC1A NBEA PALB2 SEMA3D TLE3 GNB5 CSTF1 WDFY3 CFAP57 | 6.76e-05 | 335 | 228 | 14 | IPR015943 |
| Domain | ATPase_P-typ_P_site | 7.18e-05 | 36 | 228 | 5 | IPR018303 | |
| Domain | P_typ_ATPase | 7.18e-05 | 36 | 228 | 5 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 7.18e-05 | 36 | 228 | 5 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 8.22e-05 | 37 | 228 | 5 | IPR008250 | |
| Domain | E1-E2_ATPase | 8.22e-05 | 37 | 228 | 5 | PF00122 | |
| Domain | WD40_repeat | DCAF6 IFT172 HERC2 WDR49 WDR48 POC1A NBEA TLE3 GNB5 CSTF1 WDFY3 CFAP57 | 1.35e-04 | 272 | 228 | 12 | IPR001680 |
| Domain | HMG_CoA_synt_AS | 1.48e-04 | 2 | 228 | 2 | IPR000590 | |
| Domain | TMEM131-like | 1.48e-04 | 2 | 228 | 2 | IPR022113 | |
| Domain | Vitellinogen_b-sht_N | 1.48e-04 | 2 | 228 | 2 | IPR015816 | |
| Domain | Lipid_transp_b-sht_shell | 1.48e-04 | 2 | 228 | 2 | IPR015819 | |
| Domain | HMG_CoA_synthase_euk | 1.48e-04 | 2 | 228 | 2 | IPR010122 | |
| Domain | HMG_CoA_synt_C | 1.48e-04 | 2 | 228 | 2 | PF08540 | |
| Domain | - | 1.48e-04 | 2 | 228 | 2 | 2.30.230.10 | |
| Domain | VITELLOGENIN | 1.48e-04 | 2 | 228 | 2 | PS51211 | |
| Domain | TMEM131_like | 1.48e-04 | 2 | 228 | 2 | PF12371 | |
| Domain | HMG_CoA_synth_N | 1.48e-04 | 2 | 228 | 2 | IPR013528 | |
| Domain | LPD_N | 1.48e-04 | 2 | 228 | 2 | SM00638 | |
| Domain | HMG_CoA_synt_C_dom | 1.48e-04 | 2 | 228 | 2 | IPR013746 | |
| Domain | Lipid_transpt_N | 1.48e-04 | 2 | 228 | 2 | IPR001747 | |
| Domain | - | 1.48e-04 | 2 | 228 | 2 | 1.25.10.20 | |
| Domain | HMG_CoA_synt_N | 1.48e-04 | 2 | 228 | 2 | PF01154 | |
| Domain | Vitellogenin_N | 1.48e-04 | 2 | 228 | 2 | PF01347 | |
| Domain | HMG_COA_SYNTHASE | 1.48e-04 | 2 | 228 | 2 | PS01226 | |
| Domain | WD40 | DCAF6 IFT172 WDR49 WDR48 POC1A NBEA TLE3 GNB5 CSTF1 WDFY3 CFAP57 | 3.55e-04 | 259 | 228 | 11 | PF00400 |
| Domain | Ig-like_fold | SIGLEC9 MCAM KIAA0319 UNC5A HAVCR1 HEPACAM NEO1 FNDC7 PTPRJ MYPN SDK1 IL23R PKHD1L1 SEMA3D IGHG1 IGHG2 IGHG3 IGHG4 KIRREL1 SORL1 | 4.31e-04 | 706 | 228 | 20 | IPR013783 |
| Domain | Vitellinogen_superhlx | 4.42e-04 | 3 | 228 | 2 | IPR011030 | |
| Domain | WD40 | DCAF6 IFT172 WDR49 WDR48 POC1A NBEA TLE3 GNB5 CSTF1 WDFY3 CFAP57 | 4.74e-04 | 268 | 228 | 11 | SM00320 |
| Domain | - | 5.95e-04 | 32 | 228 | 4 | 3.40.1110.10 | |
| Domain | - | 5.95e-04 | 32 | 228 | 4 | 2.70.150.10 | |
| Domain | Ntn_hydrolases_N | 6.70e-04 | 33 | 228 | 4 | IPR029055 | |
| Domain | Ig/MHC_CS | 7.02e-04 | 58 | 228 | 5 | IPR003006 | |
| Domain | PH_dom-like | ARHGAP42 EPB41L3 ANLN PLEKHH2 ARHGEF6 ARAP2 ANKS1A NBEA PLEK2 MTMR6 IPCEF1 WDFY3 EPB41 PLCE1 | 7.83e-04 | 426 | 228 | 14 | IPR011993 |
| Domain | IG_MHC | 8.21e-04 | 60 | 228 | 5 | PS00290 | |
| Domain | ATPase_P-typ_cyto_domN | 8.42e-04 | 35 | 228 | 4 | IPR023299 | |
| Domain | 4_1_CTD | 8.76e-04 | 4 | 228 | 2 | PF05902 | |
| Domain | G8_domain | 8.76e-04 | 4 | 228 | 2 | IPR019316 | |
| Domain | G8 | 8.76e-04 | 4 | 228 | 2 | PS51484 | |
| Domain | Pept_S1A_C1r/C1S/mannan-bd | 8.76e-04 | 4 | 228 | 2 | IPR024175 | |
| Domain | SAB | 8.76e-04 | 4 | 228 | 2 | PF04382 | |
| Domain | G8 | 8.76e-04 | 4 | 228 | 2 | SM01225 | |
| Domain | Band_4.1_C | 8.76e-04 | 4 | 228 | 2 | IPR008379 | |
| Domain | G8 | 8.76e-04 | 4 | 228 | 2 | PF10162 | |
| Domain | SAB_dom | 8.76e-04 | 4 | 228 | 2 | IPR007477 | |
| Domain | ATPase_P-typ_TM_dom | 8.94e-04 | 16 | 228 | 3 | IPR023298 | |
| Domain | - | 8.94e-04 | 16 | 228 | 3 | 1.20.1110.10 | |
| Domain | ARM-type_fold | GBF1 IFT172 SARM1 CLASP2 INSC UNC79 ZBTB7C UBR4 NBEA APOB AP4E1 WDFY3 | 9.80e-04 | 339 | 228 | 12 | IPR016024 |
| Domain | ATPase_P-typ_cation-transptr_C | 1.08e-03 | 17 | 228 | 3 | IPR006068 | |
| Domain | Cation_ATPase_C | 1.08e-03 | 17 | 228 | 3 | PF00689 | |
| Domain | Cation_ATPase_N | 1.28e-03 | 18 | 228 | 3 | PF00690 | |
| Domain | Cation_ATPase_N | 1.28e-03 | 18 | 228 | 3 | SM00831 | |
| Domain | EGF-like_CS | 1.43e-03 | 261 | 228 | 10 | IPR013032 | |
| Domain | TSP_3 | 1.45e-03 | 5 | 228 | 2 | PF02412 | |
| Domain | TSP3 | 1.45e-03 | 5 | 228 | 2 | PS51234 | |
| Domain | TSP_CTER | 1.45e-03 | 5 | 228 | 2 | PS51236 | |
| Domain | Thrombospondin_3_rpt | 1.45e-03 | 5 | 228 | 2 | IPR017897 | |
| Domain | TSP_type-3_rpt | 1.45e-03 | 5 | 228 | 2 | IPR028974 | |
| Domain | DUF4704 | 1.45e-03 | 5 | 228 | 2 | IPR031570 | |
| Domain | DUF4704 | 1.45e-03 | 5 | 228 | 2 | PF15787 | |
| Domain | - | 1.45e-03 | 5 | 228 | 2 | 4.10.1080.10 | |
| Domain | Thrombospondin_C | 1.45e-03 | 5 | 228 | 2 | IPR008859 | |
| Domain | TSP_C | 1.45e-03 | 5 | 228 | 2 | PF05735 | |
| Domain | Thrombospondin_3-like_rpt | 1.45e-03 | 5 | 228 | 2 | IPR003367 | |
| Domain | ATPase_P-typ_cation-transptr_N | 1.51e-03 | 19 | 228 | 3 | IPR004014 | |
| Domain | Sec23/24_helical_dom | 2.15e-03 | 6 | 228 | 2 | IPR006900 | |
| Domain | Sec23_24_beta_S | 2.15e-03 | 6 | 228 | 2 | IPR012990 | |
| Domain | zf-Sec23_Sec24 | 2.15e-03 | 6 | 228 | 2 | PF04810 | |
| Domain | Sec23_trunk | 2.15e-03 | 6 | 228 | 2 | PF04811 | |
| Domain | Sec23_helical | 2.15e-03 | 6 | 228 | 2 | PF04815 | |
| Domain | PH_BEACH | 2.15e-03 | 6 | 228 | 2 | PF14844 | |
| Domain | Sec23_BS | 2.15e-03 | 6 | 228 | 2 | PF08033 | |
| Domain | Sec23/24_trunk_dom | 2.15e-03 | 6 | 228 | 2 | IPR006896 | |
| Domain | Znf_Sec23_Sec24 | 2.15e-03 | 6 | 228 | 2 | IPR006895 | |
| Domain | SEA | 2.33e-03 | 22 | 228 | 3 | PF01390 | |
| Domain | SEA | 2.65e-03 | 23 | 228 | 3 | PS50024 | |
| Domain | SEA_dom | 2.65e-03 | 23 | 228 | 3 | IPR000082 | |
| Domain | HAD-like_dom | 2.81e-03 | 79 | 228 | 5 | IPR023214 | |
| Domain | IG_LIKE | SIGLEC9 MCAM UNC5A HAVCR1 HEPACAM NEO1 MYPN SDK1 SEMA3D IGHG1 IGHG2 IGHG3 IGHG4 KIRREL1 | 2.94e-03 | 491 | 228 | 14 | PS50835 |
| Domain | CUB | 2.98e-03 | 49 | 228 | 4 | PF00431 | |
| Domain | ZnF_UBR1 | 2.99e-03 | 7 | 228 | 2 | SM00396 | |
| Domain | ZF_UBR | 2.99e-03 | 7 | 228 | 2 | PS51157 | |
| Domain | zf-UBR | 2.99e-03 | 7 | 228 | 2 | PF02207 | |
| Domain | Znf_UBR | 2.99e-03 | 7 | 228 | 2 | IPR003126 | |
| Domain | CUB | 3.21e-03 | 50 | 228 | 4 | SM00042 | |
| Domain | - | ARHGAP42 EPB41L3 ANLN PLEKHH2 ARHGEF6 ARAP2 ANKS1A PLEK2 MTMR6 IPCEF1 EPB41 PLCE1 | 3.21e-03 | 391 | 228 | 12 | 2.30.29.30 |
| Pathway | REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT | 4.50e-05 | 54 | 170 | 6 | MM14655 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ABCA2 ATP6AP1 ATP7B SLC5A7 SLC22A7 FBXL5 SLC13A4 UNC79 SLC27A6 SLC26A2 NGB APOB ATP9A SLC7A9 SLC35A3 ATP2C1 GNB5 MTTP SLC5A8 ATP2B1 ATP4A | 7.18e-05 | 681 | 170 | 21 | MM14985 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ABCA2 ATP6AP1 ATP7B SLC5A7 SLC22A7 FBXL5 SLC13A4 UNC79 SLC27A6 SLC26A2 NGB APOB ATP9A SLC7A9 SLC35A3 ATP2C1 GNB5 MTTP SLC5A8 AKAP1 ATP2B1 ATP4A | 7.55e-05 | 736 | 170 | 22 | M27287 |
| Pathway | REACTOME_CLASSICAL_ANTIBODY_MEDIATED_COMPLEMENT_ACTIVATION | 9.93e-05 | 39 | 170 | 5 | MM17212 | |
| Pathway | WP_EICOSANOID_SYNTHESIS | 1.26e-04 | 22 | 170 | 4 | MM15961 | |
| Pubmed | ATP6AP1 GBF1 ATP7B ZFYVE16 RUNDC3B MCAM RABL3 NEO1 SEC24B TMEM131L ADAM17 GOLGA3 DOP1B TDRKH SLC26A2 ST7 NBEA ATP9A NDC1 TMEM131 AKAP1 ATP4A | 5.11e-12 | 504 | 233 | 22 | 34432599 | |
| Pubmed | MYO1C SEC24A LCN8 MCAM CLASP2 EPB41L3 RABL3 NEO1 SEC24B AFDN SDK1 GOLGA3 ARAP2 SMAP1 TDRKH MUC16 NBEA APOB CEP192 PKHD1L1 AP4E1 NDC1 KIRREL1 PARD3 AKAP1 EPB41 | 2.11e-11 | 777 | 233 | 26 | 35844135 | |
| Pubmed | NCKAP1 ZFYVE16 IFT172 RUSC2 KIAA0319 UNC5A ARAP2 DOP1B WDR48 UNC13B CEP192 ATP9A USP8 TENM4 TLE3 SPHKAP ASXL2 PLCE1 | 3.84e-10 | 407 | 233 | 18 | 12693553 | |
| Pubmed | 7.12e-10 | 8 | 233 | 5 | 32601467 | ||
| Pubmed | 7.12e-10 | 8 | 233 | 5 | 18378701 | ||
| Pubmed | Highly specific anti-estradiol antibodies: structural characterisation and binding diversity. | 1.96e-09 | 4 | 233 | 4 | 11812141 | |
| Pubmed | 1.96e-09 | 4 | 233 | 4 | 6794027 | ||
| Pubmed | Further evidence that BALB/c and C57BL/6 gamma 2a genes originate from two distinct isotypes. | 1.96e-09 | 4 | 233 | 4 | 2510996 | |
| Pubmed | Sialic acid residues are essential for the anaphylactic activity of murine IgG1 antibodies. | 1.96e-09 | 4 | 233 | 4 | 19050247 | |
| Pubmed | 1.96e-09 | 4 | 233 | 4 | 7892607 | ||
| Pubmed | Shutdown of class switch recombination by deletion of a switch region control element. | 1.96e-09 | 4 | 233 | 4 | 8438159 | |
| Pubmed | 1.96e-09 | 4 | 233 | 4 | 4098598 | ||
| Pubmed | 1.96e-09 | 4 | 233 | 4 | 6253932 | ||
| Pubmed | Immunoglobulin gamma 1 heavy chain gene: structural gene sequences cloned in a bacterial plasmid. | 1.96e-09 | 4 | 233 | 4 | 6769752 | |
| Pubmed | 1.96e-09 | 4 | 233 | 4 | 1542303 | ||
| Pubmed | 1.96e-09 | 4 | 233 | 4 | 9725203 | ||
| Pubmed | 1.96e-09 | 4 | 233 | 4 | 4831970 | ||
| Pubmed | 1.96e-09 | 4 | 233 | 4 | 12209645 | ||
| Pubmed | 1.96e-09 | 4 | 233 | 4 | 116231 | ||
| Pubmed | Nucleotide sequences of gene segments encoding membrane domains of immunoglobulin gamma chains. | 1.96e-09 | 4 | 233 | 4 | 6283537 | |
| Pubmed | 1.96e-09 | 4 | 233 | 4 | 6777755 | ||
| Pubmed | 1.96e-09 | 4 | 233 | 4 | 6297797 | ||
| Pubmed | Evolution of immunoglobulin subclasses. Primary structure of a murine myeloma gamma1 chain. | 1.96e-09 | 4 | 233 | 4 | 98524 | |
| Pubmed | Gene segments encoding transmembrane carboxyl termini of immunoglobulin gamma chains. | 1.96e-09 | 4 | 233 | 4 | 6799207 | |
| Pubmed | 1.96e-09 | 4 | 233 | 4 | 6787604 | ||
| Pubmed | Rearrangement of immunoglobulin gamma 1-chain gene and mechanism for heavy-chain class switch. | 1.96e-09 | 4 | 233 | 4 | 6767246 | |
| Pubmed | 1.96e-09 | 4 | 233 | 4 | 12051834 | ||
| Pubmed | 1.96e-09 | 4 | 233 | 4 | 8683112 | ||
| Pubmed | 1.96e-09 | 4 | 233 | 4 | 6804950 | ||
| Pubmed | Integrin-dependent organization and bidirectional vesicular traffic at cytotoxic immune synapses. | 1.96e-09 | 4 | 233 | 4 | 19592272 | |
| Pubmed | 1.96e-09 | 4 | 233 | 4 | 10720538 | ||
| Pubmed | 1.96e-09 | 4 | 233 | 4 | 15699144 | ||
| Pubmed | 1.96e-09 | 4 | 233 | 4 | 2513486 | ||
| Pubmed | Independent immunoglobulin class-switch events occurring in a single myeloma cell line. | 1.96e-09 | 4 | 233 | 4 | 3921826 | |
| Pubmed | Sequence analysis of cloned cDNA encoding part of an immunoglobulin heavy chain. | 1.96e-09 | 4 | 233 | 4 | 113776 | |
| Pubmed | Spontaneous deletions in Ig heavy chain genes: flanking sequences influence splice site selection. | 1.96e-09 | 4 | 233 | 4 | 1754385 | |
| Pubmed | An autoimmune disease variant of IgG1 modulates B cell activation and differentiation. | 1.96e-09 | 4 | 233 | 4 | 30287618 | |
| Pubmed | 1.96e-09 | 4 | 233 | 4 | 4565406 | ||
| Pubmed | IgG1 protects against renal disease in a mouse model of cryoglobulinaemia. | 1.96e-09 | 4 | 233 | 4 | 25363774 | |
| Pubmed | 1.96e-09 | 4 | 233 | 4 | 20621099 | ||
| Pubmed | Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A/Memphis/31/98). | 1.96e-09 | 4 | 233 | 4 | 12414967 | |
| Pubmed | Mouse immunoglobulin allotypes: post-duplication divergence of gamma 2a and gamma 2b chain genes. | 1.96e-09 | 4 | 233 | 4 | 6803173 | |
| Pubmed | 1.96e-09 | 4 | 233 | 4 | 6264445 | ||
| Pubmed | 1.96e-09 | 4 | 233 | 4 | 2878362 | ||
| Pubmed | IgG1 deficiency exacerbates experimental autoimmune myasthenia gravis in BALB/c mice. | 1.96e-09 | 4 | 233 | 4 | 25867470 | |
| Pubmed | Nucleotide sequences of all the gamma gene loci of murine immunoglobulin heavy chains. | 1.96e-09 | 4 | 233 | 4 | 9126488 | |
| Pubmed | 1.96e-09 | 4 | 233 | 4 | 8452816 | ||
| Pubmed | 1.96e-09 | 4 | 233 | 4 | 7439686 | ||
| Pubmed | 1.96e-09 | 4 | 233 | 4 | 6278424 | ||
| Pubmed | 1.96e-09 | 4 | 233 | 4 | 35133976 | ||
| Pubmed | 1.96e-09 | 4 | 233 | 4 | 8099342 | ||
| Pubmed | Ubiquitination of IgG1 cytoplasmic tail modulates B-cell signalling and activation. | 1.96e-09 | 4 | 233 | 4 | 32006024 | |
| Pubmed | Sequence of the cloned gene for the constant region of murine gamma 2b immunoglobulin heavy chain. | 1.96e-09 | 4 | 233 | 4 | 117549 | |
| Pubmed | 1.96e-09 | 4 | 233 | 4 | 25451975 | ||
| Pubmed | Somatic mutation in genes for the variable portion of the immunoglobulin heavy chain. | 1.96e-09 | 4 | 233 | 4 | 6801765 | |
| Pubmed | 1.96e-09 | 4 | 233 | 4 | 6306571 | ||
| Pubmed | 1.96e-09 | 4 | 233 | 4 | 1672339 | ||
| Pubmed | Recognition of a cell-surface oligosaccharide of pathogenic Salmonella by an antibody Fab fragment. | 1.96e-09 | 4 | 233 | 4 | 1713710 | |
| Pubmed | The roles of gamma 1 heavy chain membrane expression and cytoplasmic tail in IgG1 responses. | 1.96e-09 | 4 | 233 | 4 | 9103199 | |
| Pubmed | 1.96e-09 | 4 | 233 | 4 | 38268239 | ||
| Pubmed | 1.96e-09 | 4 | 233 | 4 | 6170065 | ||
| Pubmed | Distinction of the memory B cell response to cognate antigen versus bystander inflammatory signals. | 1.96e-09 | 4 | 233 | 4 | 19703988 | |
| Pubmed | Genes for immunoglobulin heavy chain and serum prealbumin protein are linked in mouse. | 1.96e-09 | 4 | 233 | 4 | 807855 | |
| Pubmed | 1.96e-09 | 4 | 233 | 4 | 4166666 | ||
| Pubmed | 1.96e-09 | 4 | 233 | 4 | 26201558 | ||
| Pubmed | 1.96e-09 | 4 | 233 | 4 | 6249338 | ||
| Pubmed | 1.96e-09 | 4 | 233 | 4 | 24752300 | ||
| Pubmed | 1.96e-09 | 4 | 233 | 4 | 36763580 | ||
| Pubmed | 1.96e-09 | 4 | 233 | 4 | 6262729 | ||
| Pubmed | Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid. | 1.96e-09 | 4 | 233 | 4 | 26683050 | |
| Pubmed | Complete nucleotide sequence of immunoglobulin gamma2b chain gene cloned from newborn nouse DNA. | 1.96e-09 | 4 | 233 | 4 | 6766534 | |
| Pubmed | Exon shuffling generates an immunoglobulin heavy chain gene. | 9.76e-09 | 5 | 233 | 4 | 6769120 | |
| Pubmed | Chromosomal location of the structural gene cluster encoding murine immunoglobulin heavy chains. | 9.76e-09 | 5 | 233 | 4 | 6770027 | |
| Pubmed | A novel allele for inducible Cre expression in germinal center BÂ cells. | 9.76e-09 | 5 | 233 | 4 | 30359469 | |
| Pubmed | 9.76e-09 | 5 | 233 | 4 | 23423996 | ||
| Pubmed | 9.76e-09 | 5 | 233 | 4 | 32229726 | ||
| Pubmed | 9.76e-09 | 5 | 233 | 4 | 33025844 | ||
| Pubmed | 9.76e-09 | 5 | 233 | 4 | 27167731 | ||
| Pubmed | Murine IgG1 complexes trigger immune effector functions predominantly via Fc gamma RIII (CD16). | 9.76e-09 | 5 | 233 | 4 | 9743367 | |
| Pubmed | Cre-loxP-mediated gene replacement: a mouse strain producing humanized antibodies. | 9.76e-09 | 5 | 233 | 4 | 7704573 | |
| Pubmed | Channel catfish soluble FcmuR binds conserved linear epitopes present on Cmu3 and Cmu4. | 9.76e-09 | 5 | 233 | 4 | 20031218 | |
| Pubmed | 9.76e-09 | 5 | 233 | 4 | 9834201 | ||
| Pubmed | 9.76e-09 | 5 | 233 | 4 | 103631 | ||
| Pubmed | 9.76e-09 | 5 | 233 | 4 | 33163250 | ||
| Pubmed | 9.76e-09 | 5 | 233 | 4 | 37310381 | ||
| Pubmed | 9.76e-09 | 5 | 233 | 4 | 36853944 | ||
| Pubmed | The disulphide bridges of a mouse immunoglobulin G1 protein. | 9.76e-09 | 5 | 233 | 4 | 5073237 | |
| Pubmed | Preneoplastic somatic mutations including MYD88L265P in lymphoplasmacytic lymphoma. | 9.76e-09 | 5 | 233 | 4 | 35044826 | |
| Pubmed | Sequential class switching is required for the generation of high affinity IgE antibodies. | 9.76e-09 | 5 | 233 | 4 | 22249450 | |
| Pubmed | The FOXO1 Transcription Factor Instructs the Germinal Center Dark Zone Program. | 9.76e-09 | 5 | 233 | 4 | 26620759 | |
| Pubmed | 9.76e-09 | 5 | 233 | 4 | 32640012 | ||
| Pubmed | Brg1 Supports B Cell Proliferation and Germinal Center Formation Through Enhancer Activation. | 9.76e-09 | 5 | 233 | 4 | 34539636 | |
| Pubmed | 9.76e-09 | 5 | 233 | 4 | 3031474 | ||
| Pubmed | 9.76e-09 | 5 | 233 | 4 | 36779803 | ||
| Pubmed | Organization, structure, and assembly of immunoglobulin heavy chain diversity DNA segments. | 9.76e-09 | 5 | 233 | 4 | 6798155 | |
| Pubmed | IgG1 cytoplasmic tail is essential for cell surface expression in Igβ down-regulated cells. | 9.76e-09 | 5 | 233 | 4 | 24548411 | |
| Pubmed | Repetitive sequences in class-switch recombination regions of immunoglobulin heavy chain genes. | 9.76e-09 | 5 | 233 | 4 | 6781756 | |
| Pubmed | Molecular and cellular basis of the retrovirus resistance in I/LnJ mice. | 9.76e-09 | 5 | 233 | 4 | 16301663 | |
| Pubmed | 9.76e-09 | 5 | 233 | 4 | 9707605 | ||
| Pubmed | 2.91e-08 | 6 | 233 | 4 | 27457619 | ||
| Interaction | EBAG9 interactions | GBF1 SEC24A ESR1 EPB41L3 RABL3 NEO1 SEC24B COG5 GOLGA3 MTMR6 NDC1 KIRREL1 PARD3 ATP2B1 | 7.25e-06 | 303 | 222 | 14 | int:EBAG9 |
| Interaction | ZFPL1 interactions | GBF1 SEC24A EPB41L3 RABL3 NEO1 SEC24B COG5 GOLGA3 NBEA AP4E1 MTMR6 IGHG1 IGHG2 KIRREL1 PARD3 AKAP1 ATP2B1 | 1.04e-05 | 448 | 222 | 17 | int:ZFPL1 |
| Interaction | RAB7A interactions | ATP6AP1 GBF1 ATP7B ZFYVE16 RUNDC3B MCAM RABL3 NEO1 ANLN SEC24B TMEM131L ADAM17 RHOF GOLGA3 DOP1B TDRKH SLC26A2 ST7 NBEA ATP9A NDC1 TMEM131 AKAP1 ATP2B1 ATP4A | 1.63e-05 | 886 | 222 | 25 | int:RAB7A |
| Interaction | LGALS1 interactions | ZNF131 DCAF6 ABCA2 ENPP1 MCAM NEO1 HEG1 PTPRJ ANLN SDK1 MUC16 THBS1 PCBP2 SORL1 | 2.02e-05 | 332 | 222 | 14 | int:LGALS1 |
| Interaction | RNF43 interactions | ZFYVE16 SEC24A RABL3 ALMS1 SEC24B TMEM131L ANKS1A AP4E1 MTMR6 NDC1 NFXL1 KIRREL1 TMEM131 PARD3 PCBP2 ENPEP | 2.23e-05 | 427 | 222 | 16 | int:RNF43 |
| Interaction | GJA1 interactions | GBF1 ZFYVE16 SEC24A MCAM THSD1 RABL3 SEC24B SDK1 GOLGA3 ARAP2 NBEA APOB AP4E1 USP8 NDC1 KIRREL1 RXFP1 PARD3 ATP2B1 | 2.64e-05 | 583 | 222 | 19 | int:GJA1 |
| Interaction | RAD51AP1 interactions | 4.43e-05 | 36 | 222 | 5 | int:RAD51AP1 | |
| Interaction | RAB11A interactions | TPRA1 GBF1 ZFYVE16 ESR1 MCAM THSD1 RABL3 HEG1 PTPRJ SEC24B GOLGA3 DOP1B NBEA ATP9A AP4E1 MTMR6 NDC1 KIRREL1 WDFY3 AKAP1 ATP2B1 ATP4A EPB41 | 4.78e-05 | 830 | 222 | 23 | int:RAB11A |
| Interaction | RAB4A interactions | TPRA1 ATP7B ZFYVE16 MCAM RABL3 SEC24B GOLGA3 DOP1B NBEA ATP9A AP4E1 MTMR6 NDC1 KIRREL1 AKAP1 ATP2B1 | 5.03e-05 | 457 | 222 | 16 | int:RAB4A |
| Interaction | ARL14 interactions | 5.25e-05 | 119 | 222 | 8 | int:ARL14 | |
| GeneFamily | WD repeat domain containing | DCAF6 IFT172 WDR49 WDR48 POC1A NBEA TLE3 GNB5 CSTF1 WDFY3 CFAP57 | 3.30e-05 | 262 | 167 | 11 | 362 |
| GeneFamily | CD molecules|Gamma-glutamyltransferases | 2.07e-04 | 13 | 167 | 3 | 564 | |
| GeneFamily | Erythrocyte membrane protein band 4.1|FERM domain containing | 5.03e-04 | 4 | 167 | 2 | 951 | |
| GeneFamily | CD molecules|Mucins | 9.11e-04 | 21 | 167 | 3 | 648 | |
| GeneFamily | Solute carriers | SLC5A7 SLC22A7 SLC26A8 SLC13A4 SLC22A14 SLC27A6 SLC26A2 SLC35F4 SLC7A9 SLC35A3 SLC5A8 | 1.14e-03 | 395 | 167 | 11 | 752 |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.48e-03 | 181 | 167 | 7 | 694 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 1.54e-03 | 134 | 167 | 6 | 861 | |
| GeneFamily | Ubiquitin protein ligase E3 component n-recognins | 1.73e-03 | 7 | 167 | 2 | 785 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 2.37e-03 | 29 | 167 | 3 | 396 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 2.93e-03 | 9 | 167 | 2 | 1230 | |
| GeneFamily | ATPases Ca2+ transporting | 2.93e-03 | 9 | 167 | 2 | 1209 | |
| GeneFamily | Fibronectin type III domain containing | 3.74e-03 | 160 | 167 | 6 | 555 | |
| Coexpression | GSE30083_SP2_VS_SP4_THYMOCYTE_UP | SARM1 MCAM NEO1 ACSM3 GOT1 TDRKH ANK2 ATP9A TENM4 REG3A AKAP1 | 1.77e-06 | 200 | 231 | 11 | M5034 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | GBF1 NCKAP1 ZFYVE16 SEC24A ZMYM2 CLASP2 HEG1 SEC24B TMEM131L ADAM17 COG5 ARAP2 DOP1B ANKS1A CEMIP MSH6 SLC35A3 ATP2C1 TMEM131 WDFY3 PARD3 ATP2B1 PLCE1 | 2.33e-06 | 856 | 231 | 23 | M4500 |
| Coexpression | GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_UP | GRAMD4 SEC24B TMEM131L DOP1B ANKS1A UBR4 XDH KATNA1 THBS1 CMTM7 | 1.21e-05 | 200 | 231 | 10 | M9455 |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_500 | ESR1 IFIH1 HEG1 PTPRQ C1S PLEKHH2 VEGFD ARHGEF6 PRRX1 DDX60 MUC16 XDH SEMA3D THBS1 THBS4 CD34 PLCE1 | 1.62e-06 | 408 | 223 | 17 | gudmap_kidney_adult_RenalCapsule_500 |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_1000 | KCTD9 MYO1C ESR1 IFIH1 HEG1 PTPRQ C1S GFPT2 PLEKHH2 VEGFD ARHGEF6 ARAP2 PRRX1 DDX60 MUC16 XDH SEMA3D THBS1 THBS4 NMI CD34 AGMO PLCE1 | 8.25e-06 | 778 | 223 | 23 | gudmap_kidney_adult_RenalCapsule_1000 |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000_k-means-cluster#5 | 4.26e-05 | 89 | 223 | 7 | Arv_SC-hpx_blastocyst_1000_K5 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#4_top-relative-expression-ranked_500 | 5.66e-05 | 64 | 223 | 6 | gudmap_kidney_adult_RenalCapsule_k4_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_top-relative-expression-ranked_1000 | MYO1C ENPP1 CLASP2 HMGCS2 EPB41L3 C1S VEGFD ARAP2 PRRX1 DDX60 PCDH20 SEMA3D THBS1 IPCEF1 CD34 AGMO ASXL2 DUSP10 ENPEP PLCE1 SORL1 | 7.17e-05 | 774 | 223 | 21 | gudmap_developingLowerUrinaryTract_P1_ureter_1000 |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | ARHGAP42 UBR1 ATP6AP1 MCAM PIPOX HMGCS2 GGT1 C1S VEGFD ARHGEF6 ARAP2 P4HA2 SEMA3D THBS1 THBS4 CD34 DUSP10 WDFY3 SLC5A8 ATP2B1 ENPEP PLCE1 SORL1 | 8.65e-05 | 905 | 223 | 23 | gudmap_kidney_P0_JuxtaGlom_Ren1_1000 |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_500_k-means-cluster#4 | 1.07e-04 | 24 | 223 | 4 | Arv_SC-H9hpx_500_K4 | |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.28e-04 | 74 | 223 | 6 | Arv_SC-H9hpx_1000_K1 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | HMGCS2 COG5 SLC27A6 CEP192 THBS1 TENM4 TLE3 AGMO KIRREL1 ENPEP SORL1 | 1.63e-09 | 170 | 232 | 11 | ba4ba66b624089ed50a9083176386c7941b4c7a3 |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | GGTLC2 EPB41L3 SLC22A7 HAVCR1 UNC79 P4HA2 SLC7A9 AGMO SLC5A8 ENPEP | 4.10e-08 | 181 | 232 | 10 | 9542c19edc9bd2cba68c01c2a8407705398e3011 |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | GGTLC2 EPB41L3 SLC22A7 HAVCR1 UNC79 P4HA2 SLC7A9 AGMO SLC5A8 ENPEP | 4.10e-08 | 181 | 232 | 10 | 8f04f8cac5d705dc5f6cf6f4516d6e45b0aa4ae5 |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | ARHGAP42 MASP1 HAVCR1 SDK1 IPCEF1 AGMO SLC5A8 PARD3 CMTM7 ENPEP | 5.30e-08 | 186 | 232 | 10 | f28d72b47624b69a580b4429e2be560a26898591 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | ARHGAP42 HAVCR1 ACSM3 SDK1 ANK2 IPCEF1 AGMO WDFY3 PARD3 ENPEP | 5.57e-08 | 187 | 232 | 10 | 9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7 |
| ToppCell | 368C|World / Donor, Lineage, Cell class and subclass (all cells) | 9.08e-08 | 197 | 232 | 10 | f41211923938e5d7bfe6bf24f604ab386f17ef10 | |
| ToppCell | COVID-19_Moderate-multiplets|World / disease group, cell group and cell class | 1.36e-07 | 156 | 232 | 9 | afdc025fa75e7926b1cc182c4a33654a2186abb1 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.38e-07 | 179 | 232 | 9 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.59e-07 | 180 | 232 | 9 | 2ccc77d769d3ffd77ab3af45e4f192785b6db79c | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | SLC22A14 C1S GFPT2 ZBTB7C MUC16 PKHD1L1 SEMA3D KIRREL1 PLCE1 | 4.81e-07 | 181 | 232 | 9 | 330d4322f4c4373f706273c1f4e218b59051b7fd |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | SLC22A14 C1S GFPT2 ZBTB7C MUC16 PKHD1L1 SEMA3D KIRREL1 PLCE1 | 4.81e-07 | 181 | 232 | 9 | 3f4d5d79c1286614514b0e8134079d6128a2a23e |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | GGTLC2 EPB41L3 SLC22A7 HAVCR1 P4HA2 SLC7A9 AGMO SLC5A8 ENPEP | 5.03e-07 | 182 | 232 | 9 | e1e58176f533092b6b974ca1ce8b02192a6e193d |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | GGTLC2 EPB41L3 SLC22A7 HAVCR1 P4HA2 SLC7A9 AGMO SLC5A8 ENPEP | 5.03e-07 | 182 | 232 | 9 | 4a9c13932e7163fd37a3dcc4c6ca3bbea5372459 |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | GGTLC2 EPB41L3 SLC22A7 HAVCR1 P4HA2 SLC7A9 AGMO SLC5A8 ENPEP | 5.03e-07 | 182 | 232 | 9 | 57bb5a2da976464ba7c4460106bd9f692008ebd9 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.52e-07 | 184 | 232 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.52e-07 | 184 | 232 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.52e-07 | 184 | 232 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.04e-07 | 186 | 232 | 9 | 20340a5b5cc7f07386498a4ef937d6fbc9e347c4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | GGTLC2 EPB41L3 SLC22A7 HAVCR1 P4HA2 SLC7A9 AGMO SLC5A8 ENPEP | 6.32e-07 | 187 | 232 | 9 | 1b82920588f9e26ef1db244d452736d75fcfd342 |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | GGTLC2 EPB41L3 SLC22A7 HAVCR1 P4HA2 SLC7A9 AGMO SLC5A8 ENPEP | 6.32e-07 | 187 | 232 | 9 | c1e4c0345f9bfa0538730bad5ff3fa5240168b25 |
| ToppCell | NS-moderate-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.21e-07 | 190 | 232 | 9 | 250ca4a605c1cccd77d23383e4fe6f91cf3609ba | |
| ToppCell | facs-Skin|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.54e-07 | 191 | 232 | 9 | ae524103331fa53fa82888dbb567fc36abcee7e0 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.87e-07 | 192 | 232 | 9 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.87e-07 | 192 | 232 | 9 | bf1943715085c4124b1675888b0615c9500ec888 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.58e-07 | 194 | 232 | 9 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | Transverse-B_cell-B_cell_IgG_Plasma|B_cell / Region, Cell class and subclass | 9.75e-07 | 197 | 232 | 9 | a0a096e8e80763a92d5d7396eb678a4587771a3a | |
| ToppCell | MS-IIF-Lymphocyte-B-Plasmablast|IIF / Disease, condition lineage and cell class | 9.75e-07 | 197 | 232 | 9 | 1b5ac53297cc557e08b9e8e511c2385a38f56bd6 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 9.75e-07 | 197 | 232 | 9 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.11e-06 | 200 | 232 | 9 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | 15-Distal-Epithelial-Multiciliated_precursor|Distal / Age, Tissue, Lineage and Cell class | 2.77e-06 | 167 | 232 | 8 | 442ea71a581ed5a547a214132b9f1b0243fd0895 | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-Deuterosomal|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.45e-06 | 172 | 232 | 8 | 08ad76412c9cc3504141797b44b88478ced87476 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.60e-06 | 173 | 232 | 8 | 30d67738633493d47f06ae452424382f069b6c0a | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.76e-06 | 174 | 232 | 8 | a9c6edf5c3fc119c24425f921c5566a8356c30fe | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.09e-06 | 176 | 232 | 8 | 3bbac5c2397535631fce8fa98f6ddb4fe0260351 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.45e-06 | 178 | 232 | 8 | bcbdd45a2307f8aea14122fa0144b96b1f6eec48 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.45e-06 | 178 | 232 | 8 | c413861148129be1ee94f2ceb5999840217eebe5 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.64e-06 | 179 | 232 | 8 | d1ef7e1cb00336118e387b47f4f8120f53584391 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-5|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 5.03e-06 | 181 | 232 | 8 | 8fcc9e77fee7c248df26b6c59b10e672242e2084 | |
| ToppCell | severe_influenza-B_memory|severe_influenza / disease group, cell group and cell class (v2) | 5.03e-06 | 181 | 232 | 8 | 92e572c92109a6dae0f73138c57c3bbd2e0a2f36 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.24e-06 | 182 | 232 | 8 | 9966f42c338cbd471efa8ffc765a6ce93693aa75 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.68e-06 | 184 | 232 | 8 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | COVID-19-Heart-Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 5.68e-06 | 184 | 232 | 8 | 21790cdfa3b4036ad413fd44b94e31563116f25f | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.68e-06 | 184 | 232 | 8 | 607b55022de21ddb6a2d75e085df76df7abf6624 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.68e-06 | 184 | 232 | 8 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.15e-06 | 186 | 232 | 8 | 7c1807fca590cdccf7f5734460bac228d33964ca | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.15e-06 | 186 | 232 | 8 | a417e1e21313a7e05951038cdef5ac672a9f727c | |
| ToppCell | wk_15-18-Mesenchymal-Mesothelial-Late_mesothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.65e-06 | 188 | 232 | 8 | 38a53f99f1876359983936403aefca93281d10fd | |
| ToppCell | COPD-Epithelial-Mesothelial|COPD / Disease state, Lineage and Cell class | 6.91e-06 | 189 | 232 | 8 | 79bb2593ad5d17f94b17972884241f03a0f43770 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.91e-06 | 189 | 232 | 8 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.18e-06 | 190 | 232 | 8 | 989d4eefd22d66ecb857836f8fdbcf41e3047f84 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.18e-06 | 190 | 232 | 8 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-I|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 7.18e-06 | 190 | 232 | 8 | 59ce52a0bb8e5ffbed2622ba7b4343501d1b2abf | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.18e-06 | 190 | 232 | 8 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.18e-06 | 190 | 232 | 8 | 1bbbf0ce222e51f9fd2daca0c18d3965fd4efd31 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.47e-06 | 191 | 232 | 8 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.47e-06 | 191 | 232 | 8 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.47e-06 | 191 | 232 | 8 | 5343a527de6b0f852f45020a91f5b4869e78f13a | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.47e-06 | 191 | 232 | 8 | a25a5f9a380031fdaf57677a079f97a90f0550c0 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.76e-06 | 192 | 232 | 8 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.76e-06 | 192 | 232 | 8 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 7.76e-06 | 192 | 232 | 8 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| ToppCell | NS-critical-d_0-4-Lymphoid-NK|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.06e-06 | 193 | 232 | 8 | 1b29525c5936d1b779253b8c20f059fa091c6127 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.37e-06 | 194 | 232 | 8 | 5a519538327029ad2b880ef9647e2ac6ab3961a4 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-3|TCGA-Stomach / Sample_Type by Project: Shred V9 | 8.37e-06 | 194 | 232 | 8 | 2260cd817a6661e5eb6645b0c6786e18fd58371e | |
| ToppCell | moderate-Epithelial-FOXN4+|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.37e-06 | 194 | 232 | 8 | 5dffa578149104dda33774361e9e77b227b5f1ce | |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.37e-06 | 194 | 232 | 8 | dff3fb10372053951d41e0ccd41aac3ece6009bd | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-mesothelial_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.69e-06 | 195 | 232 | 8 | 8a9d05f7a5397836b7dfb8ae4f7c4896042ac0fe | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.01e-06 | 196 | 232 | 8 | b07db4a53ab9be9aad6fae5e45f9547db829d096 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.01e-06 | 196 | 232 | 8 | c366f980cc04abfe1c0c14746c11810c812a42c0 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.01e-06 | 196 | 232 | 8 | 147dc1ca5942df48a083cce39a9a7541430f8365 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.36e-06 | 197 | 232 | 8 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.36e-06 | 197 | 232 | 8 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.36e-06 | 197 | 232 | 8 | 8d5097898dd01cedb04cb694cb480c931e08462c | |
| ToppCell | distal-3-Epithelial-Proximal_Ciliated|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.36e-06 | 197 | 232 | 8 | 15b4d1203943ce90a7083178d4a4284d9b323071 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 9.71e-06 | 198 | 232 | 8 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 9.71e-06 | 198 | 232 | 8 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.71e-06 | 198 | 232 | 8 | 5374b0e98d669f36a0571d3c006c7bd5e3c8e87f | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-I_(AT1)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.01e-05 | 199 | 232 | 8 | 5a002d49a8b84c158f7b4d7a3e78e6a937757bb7 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.01e-05 | 199 | 232 | 8 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | COVID-19_Moderate|World / disease group, cell group and cell class | 1.01e-05 | 199 | 232 | 8 | 952fac67588ad5676f5939e3c7f8bac803c27064 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.04e-05 | 200 | 232 | 8 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Neuronal-Inhibitory|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.04e-05 | 200 | 232 | 8 | 9ff8647e2de0b538e15929dca88ebb20ff7ab043 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.04e-05 | 200 | 232 | 8 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.04e-05 | 200 | 232 | 8 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | AT1-AT2_cells-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 1.12e-05 | 145 | 232 | 7 | cd5de30fd948024e3ad043c9411ce9f2722178b2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-05 | 149 | 232 | 7 | a6406c4c9404271a2f4c615c6cd3265b2d759b12 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.33e-05 | 149 | 232 | 7 | 768877bade04ca0321593b8470b5011ad8270431 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Rxfp1_Prdm8|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.46e-05 | 151 | 232 | 7 | 090b067873740c282865e2d02cf47d5cb3dd7607 | |
| ToppCell | (05)_Ciliated-(0)_uninjured|(05)_Ciliated / shred by cell type and Timepoint | 1.75e-05 | 104 | 232 | 6 | 0039ceeb70bec569b2d5e18be68f6c97973b80f5 | |
| ToppCell | BAL-Mild-Lymphocyte-B-Plasmablast-Plasmablast-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.95e-05 | 158 | 232 | 7 | 1397078f909338fa5fa3b01748db891e5e3fc9e7 | |
| ToppCell | BAL-Mild-Lymphocyte-B-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.95e-05 | 158 | 232 | 7 | e5451cfe67e882eb0c1eca287740f8ab75370abc | |
| ToppCell | BAL-Mild-Lymphocyte-B-Plasmablast-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.95e-05 | 158 | 232 | 7 | 17a13c5719eb363f2eb8f1d4e171429c6a1ce1e9 | |
| ToppCell | IIF-Lymphocyte-B-Plasmablast|IIF / Disease, Lineage and Cell Type | 2.20e-05 | 161 | 232 | 7 | 4d78985e7b11e92591e75a4864fd769882db2d1c | |
| ToppCell | Influenza_Severe-B_memory|World / Disease group and Cell class | 2.29e-05 | 162 | 232 | 7 | 21eb96cd4fecd85dd6acbbc3760944fa1a7cff42 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-05 | 162 | 232 | 7 | de0fde4310a56dc96bfc134c44d104993526d9bc | |
| ToppCell | Mild_COVID-19-B_cell-Plasmablast|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 2.29e-05 | 162 | 232 | 7 | b67f6fb3d7f6093c8ef02398ff8fea4d0fb41a3b | |
| ToppCell | COVID-19-lung-Mesothelial|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.48e-05 | 164 | 232 | 7 | 83303e2ba52008391b8dc3fae8225ab5bcb20063 | |
| ToppCell | Influenza_Severe-B_memory|Influenza_Severe / Disease group and Cell class | 2.58e-05 | 165 | 232 | 7 | 51172acaeb667b34b8b8c7878d67cfa0c4a2dffc | |
| ToppCell | normal_Lymph_Node-T/NK_cells-CD8+/CD4+_Mixed_Th|T/NK_cells / Location, Cell class and cell subclass | 2.68e-05 | 166 | 232 | 7 | d638d356592325cded4a6cb549041cf2f8d3e62c | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.89e-05 | 168 | 232 | 7 | b8c65542a0701ae31f49d332d87a64578e24b4e3 | |
| Drug | naringenin | 1.27e-06 | 136 | 230 | 10 | CID000000932 | |
| Disease | complement C1q subcomponent measurement | 8.26e-06 | 6 | 222 | 3 | EFO_0008089 | |
| Disease | aflatoxins-related hepatocellular carcinoma (biomarker_via_orthology) | 1.44e-05 | 7 | 222 | 3 | DOID:5022 (biomarker_via_orthology) | |
| Disease | alcohol dependence (biomarker_via_orthology) | 2.29e-05 | 8 | 222 | 3 | DOID:0050741 (biomarker_via_orthology) | |
| Disease | familial atrial fibrillation | 2.53e-05 | 156 | 222 | 8 | C3468561 | |
| Disease | Persistent atrial fibrillation | 2.53e-05 | 156 | 222 | 8 | C2585653 | |
| Disease | Paroxysmal atrial fibrillation | 2.53e-05 | 156 | 222 | 8 | C0235480 | |
| Disease | Atrial Fibrillation | 3.03e-05 | 160 | 222 | 8 | C0004238 | |
| Disease | dynactin-associated protein measurement | 5.64e-05 | 2 | 222 | 2 | EFO_0801551 | |
| Disease | SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS SYNDROME | 5.64e-05 | 2 | 222 | 2 | C3542022 | |
| Disease | neural cell adhesion molecule 1 measurement | 5.64e-05 | 2 | 222 | 2 | EFO_0801826 | |
| Disease | Hereditary xanthinuria | 5.64e-05 | 2 | 222 | 2 | cv:C5779508 | |
| Disease | insulin growth factor-like family member 4 measurement | 5.64e-05 | 2 | 222 | 2 | EFO_0801701 | |
| Disease | immunoglobulin G measurement | 5.64e-05 | 2 | 222 | 2 | EFO_0020465 | |
| Disease | creatinine measurement | CYP1A2 EPB41L3 SLC22A7 ACSM3 ALMS1 PTPRJ MYPN TMEM131L PLEC PLEKHH2 P4HA2 SNUPN PKD1L3 CEMIP SLC7A9 AP4E1 ASXL2 CFAP57 PARD3 SORL1 | 7.00e-05 | 995 | 222 | 20 | EFO_0004518 |
| Disease | ameloblastin measurement | 1.68e-04 | 3 | 222 | 2 | EFO_0801377 | |
| Disease | paired immunoglobulin-like type 2 receptor alpha measurement | 1.68e-04 | 3 | 222 | 2 | EFO_0801866 | |
| Disease | secretoglobin family 1C member 1 measurement | 1.68e-04 | 3 | 222 | 2 | EFO_0802041 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 2.54e-04 | 41 | 222 | 4 | C0496956 | |
| Disease | Breast adenocarcinoma | 2.54e-04 | 41 | 222 | 4 | C0858252 | |
| Disease | di-N-acetylchitobiase measurement | 3.35e-04 | 4 | 222 | 2 | EFO_0801524 | |
| Disease | trem-like transcript 4 protein measurement | 3.35e-04 | 4 | 222 | 2 | EFO_0802160 | |
| Disease | sodium/potassium-transporting ATPase subunit alpha-1 measurement | 3.35e-04 | 4 | 222 | 2 | EFO_0802077 | |
| Disease | RING finger protein 165 measurement | 3.35e-04 | 4 | 222 | 2 | EFO_0802027 | |
| Disease | cryptic phenotype measurement | 4.32e-04 | 47 | 222 | 4 | EFO_0021487 | |
| Disease | vital capacity | MYO1C ESR1 MYPN ARHGEF6 ANAPC4 ANKS1A PRRX1 PCDHA6 APOB MLLT10 ATP9A PKD1L3 SEMA3D THBS1 GYPE AGMO MTTP DUSP10 PARD3 MYO16 PLCE1 | 4.56e-04 | 1236 | 222 | 21 | EFO_0004312 |
| Disease | cardiovascular system disease (is_implicated_in) | 5.06e-04 | 21 | 222 | 3 | DOID:1287 (is_implicated_in) | |
| Disease | Infectious Myositis | 5.55e-04 | 5 | 222 | 2 | C0158353 | |
| Disease | Agouti-signaling protein measurement | 5.55e-04 | 5 | 222 | 2 | EFO_0801357 | |
| Disease | Myositis, Focal | 5.55e-04 | 5 | 222 | 2 | C0751357 | |
| Disease | Idiopathic Inflammatory Myopathies | 5.55e-04 | 5 | 222 | 2 | C0751356 | |
| Disease | potassium voltage-gated channel subfamily E member 2 measurement | 5.55e-04 | 5 | 222 | 2 | EFO_0801901 | |
| Disease | Myositis, Proliferative | 5.55e-04 | 5 | 222 | 2 | C0544796 | |
| Disease | protein shisa-3 homolog measurement | 5.55e-04 | 5 | 222 | 2 | EFO_0801964 | |
| Disease | psoriasis, coronary artery disease | 5.55e-04 | 5 | 222 | 2 | EFO_0000676, EFO_0001645 | |
| Disease | Myositis | 5.55e-04 | 5 | 222 | 2 | C0027121 | |
| Disease | hypertension | 5.65e-04 | 307 | 222 | 9 | EFO_0000537 | |
| Disease | ascending aortic diameter | 6.88e-04 | 140 | 222 | 6 | EFO_0021787 | |
| Disease | coronary artery disease | ARHGAP42 CYP1A2 KIAA0319 IFIH1 PTPRJ C1S TMEM41B PLEKHH2 COG5 RHOF ANKS1A SETD9 TDRKH P4HA2 SLC27A6 APOB PKD1L3 AP4E1 ATP2B1 PLCE1 | 7.42e-04 | 1194 | 222 | 20 | EFO_0001645 |
| Disease | carcinoembryonic antigen-related cell adhesion molecule 1 measurement | 8.29e-04 | 6 | 222 | 2 | EFO_0801456 | |
| Disease | beta-sarcoglycan measurement | 8.29e-04 | 6 | 222 | 2 | EFO_0801422 | |
| Disease | familial combined hyperlipidemia (is_marker_for) | 8.29e-04 | 6 | 222 | 2 | DOID:13809 (is_marker_for) | |
| Disease | tumor necrosis factor-inducible gene 6 protein measurement | 8.29e-04 | 6 | 222 | 2 | EFO_0008311 | |
| Disease | multiple coagulation factor deficiency protein 2 measurement | 8.29e-04 | 6 | 222 | 2 | EFO_0801810 | |
| Disease | Hailey-Hailey disease (implicated_via_orthology) | 8.29e-04 | 6 | 222 | 2 | DOID:0050429 (implicated_via_orthology) | |
| Disease | segment polarity protein dishevelled homolog DVL-2 measurement | 8.29e-04 | 6 | 222 | 2 | EFO_0802044 | |
| Disease | metabolic syndrome | 8.33e-04 | 200 | 222 | 7 | EFO_0000195 | |
| Disease | inflammatory bowel disease (implicated_via_orthology) | 8.55e-04 | 25 | 222 | 3 | DOID:0050589 (implicated_via_orthology) | |
| Disease | Hereditary Nonpolyposis Colorectal Neoplasms | 9.61e-04 | 26 | 222 | 3 | C0009405 | |
| Disease | fibrinogen measurement, factor VII measurement | 9.63e-04 | 58 | 222 | 4 | EFO_0004619, EFO_0004623 | |
| Disease | Hereditary non-polyposis colorectal cancer syndrome | 1.08e-03 | 27 | 222 | 3 | C1112155 | |
| Disease | hypertension, COVID-19 | 1.08e-03 | 27 | 222 | 3 | EFO_0000537, MONDO_0100096 | |
| Disease | dipeptidyl peptidase 2 measurement | 1.15e-03 | 7 | 222 | 2 | EFO_0020326 | |
| Disease | Hyperuricemia | 1.15e-03 | 7 | 222 | 2 | C0740394 | |
| Disease | LDL cholesterol change measurement | 1.15e-03 | 7 | 222 | 2 | EFO_0007804 | |
| Disease | clusterin measurement | 1.15e-03 | 7 | 222 | 2 | EFO_0007655 | |
| Disease | inducible T-cell costimulator measurement | 1.15e-03 | 7 | 222 | 2 | EFO_0021967 | |
| Disease | functional brain measurement, language measurement | 1.20e-03 | 28 | 222 | 3 | EFO_0007797, EFO_0007849 | |
| Disease | Hereditary Nonpolyposis Colorectal Cancer | 1.33e-03 | 29 | 222 | 3 | C1333990 | |
| Disease | smoking status measurement, diastolic blood pressure | 1.33e-03 | 159 | 222 | 6 | EFO_0006336, EFO_0006527 | |
| Disease | Malignant neoplasm of breast | ATP7B ESR1 EPB41L3 ARID1B PER3 HERC2 VWF ANK2 UBR4 XDH PCDH20 PALB2 MSH6 THBS1 TLE3 TEKT4 ENPEP SORL1 | 1.35e-03 | 1074 | 222 | 18 | C0006142 |
| Disease | transient cerebral ischemia (implicated_via_orthology) | 1.39e-03 | 64 | 222 | 4 | DOID:224 (implicated_via_orthology) | |
| Disease | grip strength measurement | 1.41e-03 | 350 | 222 | 9 | EFO_0006941 | |
| Disease | male breast carcinoma | 1.53e-03 | 8 | 222 | 2 | EFO_0006861 | |
| Disease | kidney disease (is_marker_for) | 1.53e-03 | 8 | 222 | 2 | DOID:557 (is_marker_for) | |
| Disease | breast carcinoma (is_marker_for) | 1.56e-03 | 66 | 222 | 4 | DOID:3459 (is_marker_for) | |
| Disease | testosterone measurement | UBR1 ESR1 SLC22A7 CEP68 ARID1B PER3 PTPRJ PGAP1 MYPN ARHGEF6 ANAPC4 ANK2 SLC27A6 XDH SNUPN GPR139 MSH6 SEMA3D AGMO MYO16 | 1.63e-03 | 1275 | 222 | 20 | EFO_0004908 |
| Disease | sleep duration | 1.78e-03 | 362 | 222 | 9 | EFO_0005271 | |
| Disease | Colon Carcinoma | 1.96e-03 | 9 | 222 | 2 | C0699790 | |
| Disease | Pancreatic carcinoma, familial | 1.96e-03 | 9 | 222 | 2 | C2931038 | |
| Disease | pulse pressure measurement | ARHGAP42 MYO1C NCKAP1 ESR1 SLC22A7 CEP68 ARID1B MYPN COG5 CRISPLD1 P4HA2 ANK2 PCDHA6 NBEA PKD1L3 GRM4 TENM4 REG3A ATP2B1 ENPEP PLCE1 | 2.01e-03 | 1392 | 222 | 21 | EFO_0005763 |
| Disease | Autoinflammatory disorder | 2.30e-03 | 35 | 222 | 3 | C3860213 | |
| Disease | N6-acetyllysine measurement | 2.44e-03 | 10 | 222 | 2 | EFO_0800036 | |
| Disease | axin-2 measurement | 2.44e-03 | 10 | 222 | 2 | EFO_0801400 | |
| Disease | familial hypercholesterolemia (is_implicated_in) | 2.44e-03 | 10 | 222 | 2 | DOID:13810 (is_implicated_in) | |
| Disease | hair colour measurement | ARHGAP42 ZFYVE16 NR6A1 NEO1 HERC2 PKD1L3 TENM4 CATSPERB ASXL2 QSER1 PARD3 AKAP1 | 2.56e-03 | 615 | 222 | 12 | EFO_0007822 |
| Disease | urinary metabolite measurement | 2.65e-03 | 245 | 222 | 7 | EFO_0005116 | |
| Disease | venous thromboembolism, factor VII measurement | 2.92e-03 | 38 | 222 | 3 | EFO_0004286, EFO_0004619 | |
| Disease | smoking status measurement | ZNF131 GBF1 ESR1 PIPOX ALMS1 INSC COG5 UNC79 SDK1 GOLGA3 ARAP2 PTGES2 MLLT10 THBS4 ATP2C1 TENM4 QSER1 SORL1 | 3.10e-03 | 1160 | 222 | 18 | EFO_0006527 |
| Disease | methionine sulfone measurement | 3.54e-03 | 12 | 222 | 2 | EFO_0800072 | |
| Disease | level of Ceramide (d42:2) in blood serum | 3.54e-03 | 12 | 222 | 2 | OBA_2045186 | |
| Disease | Adverse reaction to drug | 3.76e-03 | 84 | 222 | 4 | C0041755 | |
| Disease | Drug toxicity | 3.76e-03 | 84 | 222 | 4 | C0013221 | |
| Disease | Alzheimer disease | 3.90e-03 | 485 | 222 | 10 | MONDO_0004975 | |
| Disease | tumor necrosis factor ligand superfamily member 11 measurement | 4.16e-03 | 13 | 222 | 2 | EFO_0010617 | |
| Disease | Bardet-Biedl Syndrome | 4.16e-03 | 13 | 222 | 2 | C0752166 | |
| Disease | immunoglobulin isotype switching measurement | 4.43e-03 | 44 | 222 | 3 | EFO_0010128 | |
| Disease | response to radiation | 4.44e-03 | 88 | 222 | 4 | GO_0009314 | |
| Disease | fibrinogen measurement, tissue plasminogen activator measurement | 4.72e-03 | 45 | 222 | 3 | EFO_0004623, EFO_0004791 | |
| Disease | fibrinogen measurement, plasminogen activator inhibitor 1 measurement | 4.72e-03 | 45 | 222 | 3 | EFO_0004623, EFO_0004792 | |
| Disease | response to beta blocker | 4.72e-03 | 45 | 222 | 3 | EFO_0007766 | |
| Disease | atrial fibrillation (is_implicated_in) | 4.83e-03 | 14 | 222 | 2 | DOID:0060224 (is_implicated_in) | |
| Disease | triglyceride measurement, high density lipoprotein cholesterol measurement | 4.88e-03 | 274 | 222 | 7 | EFO_0004530, EFO_0004612 | |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 5.00e-03 | 91 | 222 | 4 | EFO_0004611, EFO_0005271 | |
| Disease | Neurodevelopmental Disorders | 5.40e-03 | 93 | 222 | 4 | C1535926 | |
| Disease | acute graft vs. host disease, donor genotype effect measurement | 5.55e-03 | 15 | 222 | 2 | EFO_0004599, EFO_0007892 | |
| Disease | lateral ventricle volume change measurement | 5.55e-03 | 15 | 222 | 2 | EFO_0021502 | |
| Disease | N-acetylmethionine measurement | 5.55e-03 | 15 | 222 | 2 | EFO_0021427 | |
| Disease | mannan-binding lectin serine protease 1 measurement | 5.55e-03 | 15 | 222 | 2 | EFO_0008223 | |
| Disease | age at menarche | KCTD9 ZNF131 NR6A1 ALMS1 INSC TMEM245 UNC79 ANAPC4 PCDH20 GPR139 MSH6 | 5.61e-03 | 594 | 222 | 11 | EFO_0004703 |
| Disease | Calcium channel blocker use measurement | 5.65e-03 | 213 | 222 | 6 | EFO_0009930 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KSAYASGTTAKITSV | 1186 | P55196 | |
| SFATLALLGSYTIQS | 321 | P11171 | |
| SFLKQTSGAKIYIST | 631 | Q92667 | |
| YSGVNFSKVLSTLLA | 91 | Q15052 | |
| SIESSYSSIQKLVIS | 336 | Q9UJX5 | |
| SAITFVSQRGKVYST | 461 | Q9H7T0 | |
| QVSSLVSYLGSISTL | 491 | Q76N32 | |
| PFSSSSSQLLKIYTV | 326 | Q6ZNB7 | |
| GITYASVALATSKAL | 591 | P35670 | |
| LTFYELKTSSGSLVQ | 66 | Q8WW27 | |
| TVYTNTLLSSSVLGK | 331 | Q8IVW4 | |
| LISSAVYVKNQLSGT | 31 | Q9NZJ6 | |
| GSLFITTINKTQLSY | 246 | Q9NZJ6 | |
| FGTSQSADKLYIQTT | 806 | Q14833 | |
| SADKLYIQTTTLTVS | 811 | Q14833 | |
| ILSQYIKITSAAASG | 561 | Q6IC98 | |
| DQKTGLSTVTSSFYS | 1746 | Q8TCU4 | |
| VGTSSSAASSLKKQY | 1201 | Q8NFD5 | |
| AATATNSFIIKSSIY | 366 | Q8WZ64 | |
| FLSSGYSSIDTVKNL | 791 | Q92625 | |
| YSTEGTTTSTIKLNF | 481 | Q58WW2 | |
| LLSSGQLYSIVSSLS | 391 | Q8NB46 | |
| LSKIYSQSTLSLSTV | 1041 | Q9P1Y5 | |
| GKTLLLTSSATVYSI | 61 | Q8WUJ3 | |
| TYVGKLTLSSSAQLD | 76 | A6H8M9 | |
| STVLKNSDGSYRIFS | 586 | P20020 | |
| ASRLGLYSKTSQSVS | 581 | P98194 | |
| TTLSKENYLFTRGQT | 1241 | Q76L83 | |
| NSSGYKDLTGSFVTI | 236 | Q9UPM8 | |
| GSGLAATLYSLKVTQ | 376 | Q01581 | |
| KAYSTTSIASVAGLT | 21 | Q86Y39 | |
| KVLSTSTGLTKTVYN | 686 | Q5T8P6 | |
| PLYKTLTFSGSSQTV | 371 | Q2KHR3 | |
| VGSASSVKSTRAVFY | 71 | Q5HYI8 | |
| LYTSTLITDGQSLTF | 111 | P05177 | |
| VAIYSKESIIFGASS | 316 | O14775 | |
| DVGSNSILTYKLSSS | 161 | Q9UN73 | |
| YTKVTEFVLTGLSQT | 6 | A0A0X1KG70 | |
| QLLSISDSYGSTSLF | 156 | Q8NAB2 | |
| STLLNYGAETNIVTK | 646 | Q01484 | |
| TEGNFTKEASTYTLT | 136 | Q8WXI7 | |
| TITTQTGYSLATSQV | 9661 | Q8WXI7 | |
| YFSLDSVTGILTVST | 581 | Q8N6Y1 | |
| YGLQFTSSRKFLSIS | 91 | Q53FV1 | |
| GNYLITASSDSTLKI | 241 | Q8NBT0 | |
| STSYNISITTVSCGK | 786 | Q12913 | |
| YGTLSDLLSVASSKL | 21 | Q7L273 | |
| STIQASYFGTDKITR | 76 | Q17RR3 | |
| SLYTNAKGSTISAFD | 121 | P61244 | |
| TLNVGGKLYTTSLAT | 6 | Q4G0X4 | |
| VLKDIFTTGTSSYNV | 96 | Q8NCT3 | |
| FTTGTSSYNVLLQSK | 101 | Q8NCT3 | |
| GKILANTFITYTTQT | 121 | Q6ZNB6 | |
| NTTTAAYLASVGTRK | 266 | Q2TV78 | |
| DRFSTSNKSLTGTLY | 16 | Q9Y217 | |
| FQSKLSQTGSLVSAY | 946 | Q9Y6X6 | |
| TKLLHQTGLSLYSTS | 21 | Q9NTX5 | |
| SQFSVALTKSGAVYT | 4206 | O95714 | |
| TFTSLEAGTLYTIKA | 166 | Q5VTL7 | |
| INYTVTLKAISATGL | 601 | Q5VTL7 | |
| TSNFALVGSYTLSLS | 936 | Q9NQW6 | |
| VYTTTSLENISSLKG | 496 | Q96MR6 | |
| LSYTQSGNSLISAIK | 406 | Q9Y3R5 | |
| GSSSVYFKTTKTIRQ | 1656 | Q9Y3R5 | |
| FYGNSLETVSSKIIV | 541 | Q8IY21 | |
| IATTVVSLKAANLTY | 46 | Q9Y6W6 | |
| LSASSDTQTSLYKGL | 321 | P54868 | |
| LTSSVYSSKISQNGQ | 1071 | P56645 | |
| IILLNSGVYTFLSST | 451 | P03372 | |
| SGVYTFLSSTLKSLE | 456 | P03372 | |
| TFSQLVYTTSISEGL | 2271 | Q9NYQ8 | |
| TLSGSNLTVKVAYNS | 61 | Q6JVE9 | |
| YTKVTEFVLTGLSQT | 6 | Q8NGD0 | |
| YTKVTEFVLTGLSQT | 6 | Q8NGB6 | |
| QVLGVSSKATSVTTY | 206 | P55157 | |
| SATSTINLYFGSKVR | 51 | Q9BX51 | |
| TKSYISSQTNGITLI | 36 | P15421 | |
| SATSTINLYFGSKVR | 51 | Q14390 | |
| DYTVIFTAGSTAALK | 111 | Q96EN8 | |
| NKNSSGIYSEALLTT | 746 | P22413 | |
| TSVFDGISYSKGSSI | 471 | Q07075 | |
| SYLLTDKTGTLTQNE | 386 | O75110 | |
| VGYSLEIATALTSQS | 186 | Q9ULI3 | |
| ISSSKNSYKLVTDGT | 391 | Q9Y5G0 | |
| TVSTTRSGAIFTKAY | 716 | P52701 | |
| ALVILSSLAFTTGSY | 201 | Q8NGM8 | |
| SSASTRGTYGILSKT | 321 | Q08378 | |
| VYTTLKGKATQISSS | 601 | Q8IVE3 | |
| FRLQAYTSVSKASLG | 491 | Q9Y2A7 | |
| TESYVVSLTTNCSGK | 151 | Q9UG01 | |
| STYSIRVSAFTKVGN | 1351 | Q9UMZ3 | |
| NTSYVFKVRASTSAG | 1441 | Q9UMZ3 | |
| TGVLTVASYRVSKSS | 371 | O15460 | |
| TITGSAASISLAQYL | 336 | Q15366 | |
| SQHTKTGLSSSILLY | 691 | Q86YC2 | |
| KGGLAAYSTSVNLTS | 1026 | Q9UHC9 | |
| AQKGAAFLSITTIYA | 186 | Q16698 | |
| FYNLGTLKDTITSVV | 266 | Q9UP83 | |
| GTIASEANTYLNSKS | 3511 | P04114 | |
| ISNGDTTSFLLKVYV | 216 | Q02985 | |
| SGTSYSFSSLENTVK | 191 | Q8WWN9 | |
| IGVASTKAYTSQFIS | 471 | O94808 | |
| GQITYTATSTKSNTK | 136 | Q9H1M3 | |
| GKYQSANSFTVSKVT | 376 | Q9H336 | |
| FISTVNSLSVRLGSY | 161 | P82251 | |
| SSYINISTDSLQGGK | 176 | Q5VWK5 | |
| GIIFTKTRQSAYALS | 721 | Q9BYX4 | |
| YVGSTSVQTSRLAKS | 486 | P09871 | |
| SISVTALTAILKYGQ | 761 | Q9BZC7 | |
| SGLTTKNLDYVATSI | 391 | P17174 | |
| KGTSSSSSYIFQKIS | 361 | Q5T1N1 | |
| GLITFSTRNNLTTYK | 376 | P48740 | |
| LYTALTTQQKLAGVT | 126 | O75608 | |
| GINNKTATELSTVYL | 1971 | Q8TEP8 | |
| TTNTTFGTAVIKEYS | 381 | Q8N7U6 | |
| NIYTTESTTGNLFSL | 251 | Q1MX18 | |
| ITGLALTSVNKFLSY | 81 | Q92538 | |
| LLLKSVTQADAGTYT | 356 | Q96J84 | |
| TVGKSALLSVQYSST | 46 | Q14CZ8 | |
| FNVSSSTLTSKYRGE | 271 | O75449 | |
| VLQSSGLYSLSSVVT | 56 | P01857 | |
| VLQSSGLYSLSSVVT | 56 | P01859 | |
| VLQSSGLYSLSSVVT | 56 | P01860 | |
| VLQSSGLYSLSSVVT | 56 | P01861 | |
| SVKTLVLAYSSAVSS | 331 | Q9UKA1 | |
| ITVSQLLEYGTASNK | 2811 | Q8NDH2 | |
| YSTGKTTAILFTITS | 221 | Q6DWJ6 | |
| SAIFSKNSKYILSSG | 311 | Q05048 | |
| GGTTSLKRYQSSALT | 201 | O00321 | |
| STLVLGLASAASVSY | 181 | Q9Y694 | |
| QSVVGYAISSISLAT | 246 | Q9Y267 | |
| VVDSLSAYGSTVSNL | 1046 | O95487 | |
| KRFVVLISTLGTYNS | 351 | O00237 | |
| SISYSATIGGLTTII | 271 | Q9UKG4 | |
| KIQGLSSLTTYTIDV | 1031 | Q7Z5N4 | |
| YQTSATKGLSASLAA | 66 | P20648 | |
| VKFTSTSVITSVYGN | 91 | P28906 | |
| YSQKTLIALVTSGAL | 286 | P28906 | |
| SFVTLALLGSYTVQS | 221 | Q9Y2J2 | |
| VKLSSFSTVGESLLY | 101 | Q9NPG2 | |
| IFTTLKTYSVLQDST | 486 | Q8TE73 | |
| LGSYKAQKTSRSSSI | 361 | O14830 | |
| VSYGLIFSTVLKITS | 216 | Q15619 | |
| SVTTGQKTLTSVGYQ | 501 | Q12889 | |
| NVFSTTVSSGYNTKK | 441 | Q8TEW0 | |
| SYVSILSTILKINST | 216 | Q8NGG4 | |
| VESSGLYTLQSILKA | 196 | P43121 | |
| SLAQTSKTTTAVYVF | 431 | Q96P20 | |
| SSLTVYSKQIFGELA | 331 | Q15406 | |
| LCGSLTSVASYKSLT | 436 | Q96NL0 | |
| SSDGVLVTFSTLYNK | 276 | Q8N2Y8 | |
| VLSSSSATYAQVLSF | 261 | Q9GZV3 | |
| SFVSSLVKSIGNSYS | 86 | Q06141 | |
| YTASVTVGSKEVTLN | 56 | Q9HBH0 | |
| VTTGKYATNLAESVL | 386 | Q2M3C7 | |
| GKNLASKTNVYISSS | 511 | Q92673 | |
| IESSLFINTSSYGVL | 166 | A2VDJ0 | |
| LKNKSSASVVFTTYT | 206 | Q7L5D6 | |
| IQSTYSLANIKETGS | 646 | P30414 | |
| SISQYITGSLLEATT | 461 | Q9P212 | |
| GNKSYSGSIQSLTSV | 746 | A6NI28 | |
| VSFQSALLYTSSKGE | 801 | O95486 | |
| YNKSLSVVATTTFLT | 191 | Q96RN1 | |
| QLKNITVTSGEYSLF | 96 | Q7RTY7 | |
| SFRVYSTETGKLTQI | 2701 | Q8NFP9 | |
| SLLTANTTKGIYAGV | 286 | Q96D42 | |
| KNANATTLSYLVTGL | 906 | Q92859 | |
| SAATTAKVVITLYGS | 756 | Q7Z443 | |
| LYKTLGFSVAQATSS | 116 | Q8NE22 | |
| VYLNVSLQSKATSGV | 331 | Q9Y336 | |
| YSGTLSTVSSSINAL | 346 | Q8N695 | |
| SSGLATASFRTSKYL | 26 | Q8WW24 | |
| QVKSLSSVLSRYQGF | 121 | Q9H4K7 | |
| LGNTYTVSIKSSKLL | 866 | Q75T13 | |
| SVIISALKTYLVSGQ | 166 | Q9H7Z7 | |
| LIVASRGSTSAYTKS | 131 | O95149 | |
| KFYVALTGTSSLISG | 61 | Q9NRC1 | |
| AVGSASTSALYKVLF | 336 | A4IF30 | |
| ISTSSKGLSLSYIIQ | 1051 | Q96J65 | |
| TTTSSIFKGSAVCVY | 346 | O95025 | |
| VAFSYSGSSVAQKVT | 11 | A0A1B0GX56 | |
| TYTSTSNNSISGSLK | 266 | P55197 | |
| NSGLTSTKNYGKTIL | 381 | P78536 | |
| SKTASTLRGNFYITG | 446 | Q53FZ2 | |
| ASIVAASKSYNQSGL | 126 | Q96FZ5 | |
| QKSLQTYLKSSGSVA | 301 | O75122 | |
| LQTKSSATIFGLYSS | 66 | P35443 | |
| SATIFGLYSSTDNSK | 71 | P35443 | |
| TVLSLAYSVTQGTLE | 156 | Q86W33 | |
| QGSTYKKTFLGSSLV | 151 | Q9NYT0 | |
| QGYSGLSVKVVNSTT | 1056 | P07996 | |
| GYSLGISFLTNIVSK | 106 | Q9ULJ3 | |
| TSSLSGNKDSIYSLA | 161 | Q8TAF3 | |
| KVSFGLYALSVSSLT | 1321 | Q8IZQ1 | |
| TKTLLAILSSSQFYG | 261 | Q9NX65 | |
| LVAKISSYVQTGIST | 451 | Q9Y2W6 | |
| GSQVASTSEVLKYTL | 1351 | P04275 | |
| KSAFTILYTKGTSAT | 176 | Q2QL34 | |
| IAGITKASLTYSQLS | 371 | P60508 | |
| IQSLKRLVSYSTNGT | 371 | Q6SZW1 | |
| RLVSYSTNGTKSALA | 376 | Q6SZW1 | |
| QTSLSTLGIALKFYN | 401 | Q7RTY8 | |
| SFTILTSQAKYLLGL | 261 | P50443 | |
| TVTTKYLLTNQSQGT | 71 | Q9NS62 | |
| TTLGLSSYQQKSISL | 86 | Q92545 | |
| YNSILKQVISSDTGS | 156 | Q8IV35 | |
| TLLKNGSSLYITAVQ | 86 | A0A075B6U4 | |
| LSFGVESSIKYSNSI | 1276 | Q8IWV7 | |
| KITSISIYAFRGLNS | 161 | Q9HBX9 | |
| VTITTNLSASGAFYT | 1736 | Q6N022 | |
| SKDSILSLYGTGTIQ | 301 | Q8IYB5 | |
| STVVSTAVALAAYKT | 806 | P47989 | |
| LSLYTQTTDTLIKTF | 1391 | O14795 | |
| VSTLTTYLQEKLGAS | 141 | Q15904 | |
| TKYTGTNVSLQRISL | 801 | Q86WI1 | |
| SIYKTKLSETAFAGS | 3166 | Q86WI1 | |
| SELTTLTSQYIKFIS | 1461 | Q15149 | |
| YGASIFQSKESSSVL | 731 | Q04726 | |
| SSGTTKSQKAYIRIA | 131 | Q6ZN44 | |
| VQLSKGTKYLSTFSA | 391 | Q9Y577 | |
| IQTYTPSLTSQTKTG | 241 | Q9UBW7 | |
| TSNTSYSLEKISSLA | 886 | Q8TCN5 | |
| TLANLAISITGYESS | 281 | Q9H330 | |
| FAYTSTLTITAGNVK | 91 | A1YPR0 | |
| KYVSLGILVFQTTSL | 6 | Q9Y2D2 | |
| TYQLKILTTALFSVS | 116 | Q9Y2D2 | |
| GLLVTVKTTSRSYQA | 181 | Q9P0Z9 | |
| ASAKQSVKYIQSTGS | 191 | P52739 | |
| SFVAIKAGTTLYQLT | 241 | Q5BJD5 | |
| TSTSYISKQLFEISV | 156 | O43915 | |
| NASLLKSYSGDVTAV | 161 | P54821 | |
| KSTCLYIFTSGTTGL | 216 | Q9Y2P4 | |
| VTASSGSALQYDTLI | 3256 | Q5T4S7 | |
| IKQDSSTGSYSINFV | 271 | Q99614 | |
| ISVSSVKSSAAYILF | 1091 | P40818 | |
| STSLTIVYLGAKGTT | 36 | P48595 | |
| TSYGTNESSLNEKTL | 71 | Q7Z3T8 | |
| YFSQTLLSILSRTGK | 41 | Q9P2D8 | |
| SVSGLSQITKSLYIS | 16 | Q8NEJ0 | |
| SQITKSLYISNGVAA | 21 | Q8NEJ0 | |
| ATSTINLYFGSKVRS | 396 | P19440 | |
| STGLSSVEAYNIKSN | 411 | O95198 | |
| SQLSVGLYVFKVTVS | 396 | Q5VV43 | |
| GLSAKSTILYSSSRS | 4876 | Q9UKN1 | |
| YANLTGISVSSLSDS | 961 | O00159 | |
| TASNKYGTVSSIAQL | 516 | Q86TC9 | |
| ASLKTAIYRITTTFG | 636 | Q9BTX1 | |
| YQIFSGTSKRTVLLT | 246 | Q13287 |